• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Model Number BXA115902A
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Aneurysm (1708)
Event Date 10/13/2020
Event Type  malfunction  
Manufacturer Narrative
Patient comorbidities: previous smoker, hypertension, and previous aaa.Patient medications: aspirin and ramipril.The gore® viabahn® vbx balloon expandable endoprosthesis instructions for use (ifu) states after deploying the endoprosthesis, slowly withdraw the balloon.Observe under fluoroscopy the balloon is fully deflated prior to removal.Also if resistance is encountered upon attempted removal, do not force removal.
 
Event Description
On (b)(6) 2017, this patient underwent endovascular treatment for an abdominal aortic aneurysm with gore® excluder® aaa endoprostheses.It was reported that the right common iliac artery had become aneurysmal due to the contralateral leg endoprosthesis losing seal distally and a distal type i endoleak (date and modality of images is unknown).The physician reintervened on (b)(6) 2020 and implanted a gore® excluder® iliac branch endoprostheses and a gore® viabahn® vbx balloon expandable endoprosthesis.The endoleak was resolved.While retracting the delivery catheter (from the left brachial artery access) of the vbx, it was difficult to deflate the balloon.It was revealed that the technician put too much contrast mixed with saline to inflate the balloon, reportedly this makes it difficult to deflate the balloon.By mistake, the technician added additional contrast, as opposed to saline to the balloon.So with the balloon being not fully deflated the physician became impatient and attempted to yank the delivery catheter through the terumo destination sheath (8fr x 90cm in the brachial artery).Upon doing so, the hub of the balloon separated from the shaft of the catheter (2203-a).The physician was able to get both pieces into the sheath and then removed the sheath.There was no serious injury to the patient.The patient tolerated the procedure.
 
Manufacturer Narrative
Addition d4.Addition d8.Addition g4.Addition -the device was returned to gore for an engineering evaluation.The device was identified to be an 11 x 59 x 1350 mm configuration, which matches the event description.The gore® viabahn® vbx balloon expandable delivery system was returned with the hub detached and without the endoprosthesis mounted on it because it was successfully deployed.The delivery catheter displayed necking from the separation to 10cm down the length of the delivery system.The delivery catheter lot met specifications for tensile strength.The catheter of the vbx delivery system is 100% inspected at the end of the manufacturing process for any mechanical damage, including necking.Any devices with mechanical damage are rejected.The device history file did not indicate any anomalies occurred that would increase the force to withdraw the device.Based on the device evaluation performed, no manufacturing anomalies were identified to which the event could be definitively attributed.Addition cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10702147
MDR Text Key217673457
Report Number2017233-2020-01367
Device Sequence Number1
Product Code PRL
UDI-Device Identifier00733132637744
UDI-Public00733132637744
Combination Product (y/n)Y
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 05/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/21/2022
Device Model NumberBXA115902A
Device Catalogue NumberBXA115902A
Device Lot Number21783871
Was Device Available for Evaluation? No
Date Manufacturer Received10/13/2020
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age82 YR
Patient Weight79
-
-